Monday, August 01, 2022 10:45:20 PM
What is your theory on the good Dr. being at the NYSE 1.5 months ago?
I did buy some additional shares in the $1.70 range and again $2.5X range 2 weeks ago. I agree, this may / probably will go lower. Once people see there are near zero sales in Mexico with earnings release in next week or so and once more people realize many products have gone **POOF** never to be seen again - it will take a toll.
But I like your solid conclusion on the tightening of their belts. We have three new adults in the room and I do hope they've get board focused.
Oddly - have we heard from Tommy there as if late?
https://sorrentotherapeutics.com/who-we-are/leadership/
Elizabeth is found on leadership team but Tommy is not.
Nothing since 7/5.
Still trying to lower average cost.
I do hope we get an offer - buyout. I saw on interesting theory that coincides w/ your product reduction observations 1776 - that often times, a company will reduce / clean up its act as it preps for merger or buyout AND it often happens just after earning announcement. Only his observation. Would a $25/hare be AWESOME or what!?!
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM
- Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the A • GlobeNewswire Inc. • 06/05/2023 01:00:00 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONG • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM